APA (7th ed.) Citation

Chan, J. K., Brady, M. F., Penson, R. T., Huang, H., Birrer, M. J., Walker, J. L., . . . Monk, B. J. (2016). Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. The New England journal of medicine, 374(8), 738-748. https://doi.org/10.1056/NEJMoa1505067

Chicago Style (17th ed.) Citation

Chan, John K., et al. "Weekly Vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer." The New England Journal of Medicine 374, no. 8 (2016): 738-748. https://doi.org/10.1056/NEJMoa1505067.

MLA (9th ed.) Citation

Chan, John K., et al. "Weekly Vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer." The New England Journal of Medicine, vol. 374, no. 8, 2016, pp. 738-748, https://doi.org/10.1056/NEJMoa1505067.